Published Studies Related to Lithium Carbonate
Well-designed clinical trials related to Lithium Carbonate
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. [2009.06]
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]
Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. [2009.02]
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. [2009.02]
A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. [2009.01]
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. [2008.12]
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. [2008.12]
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. [2008.08]
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). [2008.08]
Serotonin transporter gene and response to lithium augmentation in depression. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? [2008.03]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. [2007.10]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2007.05.23]
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study. [2007.05]
Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. [2007.05]
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. [2007.04]
Lithium and triiodothyronine augmentation of antidepressants. [2006.10]
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. [2006.04]
Inositol augmentation of lithium or valproate for bipolar depression. [2006.04]
Bioequivalence of two lithium formulations in healthy volunteers. [2006]
Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. [2005.08]
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. [2005.05]
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? [2005.01]
Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study. [2005]
Well-designed clinical trials possibly related to Lithium Carbonate
Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. [2009.08]
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? [2009.05]
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). [2009.02]
Impact of remitted substance use disorders on the future course of bipolar I disorder: Findings from a clinical trial. [2008.07.15]
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. [2008.03]
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. [2007.12]
Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder. [2007.08]
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. [2007.01]
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). [2006.12]
Maintenance treatment outcomes in older patients with bipolar I disorder. [2005.04]
Cognitive therapy vs medications in the treatment of moderate to severe depression. [2005.04]
Obesity among outpatients with major depressive disorder. [2005.03]
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. [2005.01]
Other research related to Lithium Carbonate
Olanzapine vs. lithium in management of acute mania. [2009.09.07]
The effects of subchronic lithium administration in male Wistar mice on some biochemical parameters. [2009.09]
No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS. [2009.08.03]
Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. [2009.08]
[Intoxication with lithium] [2009.06.24]
Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability. [2009.06]
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. [2009.06]
The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. [2009.06]
A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. [2009.05]
[Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane] [2009.04.30]
Pseudotumor cerebri associated with lithium use in an 11-year-old boy. [2009.04]
Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. [2009.01]
[Concomitant lithium and methadone treatment in a bipolar patient: a case report] [2009]
Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. [2009]
Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. [2008.11]
Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion. [2008.10]
[Predictors of prophylactic response to lithium] [2008.09]
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. [2008.08]
Alert: inaccurate lithium assay results. [2008.07]
Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. [2008.05.30]
Encephalopathy with combined lithium-risperidone administration. [2008.05]
A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. [2008.05]
Lithium treatments: single and multiple daily dosing. [2008.05]
Complete atrioventricular block secondary to lithium therapy. [2008.05]
Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. [2008.05]
Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study. [2008.04]
Prediction of optimal lithium doses for Taiwanese psychiatric patients. [2008.04]
Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. [2008.04]
Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review. [2008.02]
[Development of sustained vasodilatory shock and permanent loss of hearing after severe lithium carbonate poisoning.] [2008.01.28]
Detoxication treatment for carbamazepine and lithium overdose. [2008.01]
The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients. [2008]
Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. [2008]
Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case. [2007.12]
Effects of lithium on brain glucose metabolism in healthy men. [2007.12]
Lithium in mood disorders: increasing evidence base, declining use? [2007.12]
Neuroprotective effects of zinc on antioxidant defense system in lithium treated rat brain. [2007.11]
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. [2007.11]
Update: new uses for lithium and anticonvulsants. [2007.11]
Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. [2007.11]
[Twenty-five years of lithium augmentation] [2007.11]
Clozapine-induced leukopenia successfully treated with lithium. [2007.10.01]
Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. [2007.09.05]
Spatial distribution of lithium ions in glasses studied by (7)Li{(6)Li} spin echo double resonance. [2007.08.14]
Spatial distribution of lithium ions in glasses studied by 7Li{6Li} spin echo double resonance. [2007.08.14]
Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass. [2007.08]
A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. [2007.08]
Lithium: underappreciated and underused? [2007.08]
Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. [2007.08]
Hypercalcemia and diabetes insipidus in a patient previously treated with lithium. [2007.07]
Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. [2007.06]
Application of the Cockcroft-Gault method to estimate lithium dosage requirement. [2007.06]
Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. [2007.06]
Lithium toxicity from an Internet dietary supplement. [2007.06]
Fifteen-year follow-up of thyroid function in lithium patients. [2007.05]
Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status. [2007.05]
Lithium normalizes elevated intracellular sodium. [2007.05]
Oral administration of lithium increases tissue magnesium contents but not plasma magnesium level in rats. [2007.05]
Effect of prior exposure to a lithium- and an amphetamine-paired flavor on the acoustic startle response in rats. [2007.04]
Late onset nephrogenic diabetes insipidus following cessation of lithium therapy. [2007.04]
Permanent lithium-induced cerebellar toxicity: three cases and review of literature. [2007.03.15]
|
